Similar articles for PMID: 32487552

Year	Number of Results
1992	1
1993	1
1994	1
1999	1
2001	1
2004	1
2005	2
2006	1
2007	5
2008	3
2009	3
2011	3
2012	1
2013	3
2014	2
2015	11
2016	12
2017	13
2018	15
2019	17
2020	12
2021	5
2024	0

1

Vertebral fractures after denosumab cessation.

Dupont J, Laurent MR, Dedeyne L, Luyten FP, Gielen E, Dejaeger M. Dupont J, et al. Cleve Clin J Med. 2020 Jun;87(6):337-338. doi: 10.3949/ccjm.87a.19152. Cleve Clin J Med. 2020. PMID: 32487552 Free article. No abstract available.

2

Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.

Lehmann T, Aeberli D. Lehmann T, et al. Osteoporos Int. 2017 Oct;28(10):3067-3068. doi: 10.1007/s00198-017-4108-y. Epub 2017 Jun 6. Osteoporos Int. 2017. PMID: 28589418 No abstract available.

3

Moretti A, Gimigliano F, Di Pietro G, Gimigliano R, Iolascon G. Moretti A, et al. Aging Clin Exp Res. 2015 Oct;27 Suppl 1:S3-9. doi: 10.1007/s40520-015-0428-y. Epub 2015 Jul 26. Aging Clin Exp Res. 2015. PMID: 26210371

4

Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review.

Diédhiou D, Cuny T, Sarr A, Norou Diop S, Klein M, Weryha G. Diédhiou D, et al. Ann Endocrinol (Paris). 2015 Dec;76(6):650-7. doi: 10.1016/j.ando.2015.10.009. Epub 2015 Nov 27. Ann Endocrinol (Paris). 2015. PMID: 26639186 Review.

5

Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report.

Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B. Lamy O, et al. J Clin Endocrinol Metab. 2017 Feb 1;102(2):354-358. doi: 10.1210/jc.2016-3170. J Clin Endocrinol Metab. 2017. PMID: 27732330

6

Identifying Multi-Level Vertebral Compression Fractures Following a Convulsive Seizure.

Rahamimov N, Arnon-Sheleg E. Rahamimov N, et al. Isr Med Assoc J. 2021 Aug;23(8):526-528. Isr Med Assoc J. 2021. PMID: 34392631 Free article. No abstract available.

7

Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.

Aubry-Rozier B, Gonzalez-Rodriguez E, Stoll D, Lamy O. Aubry-Rozier B, et al. Osteoporos Int. 2016 May;27(5):1923-5. doi: 10.1007/s00198-015-3380-y. Epub 2015 Oct 28. Osteoporos Int. 2016. PMID: 26510845

8

Denosumab: a novel antiresorptive drug for osteoporosis.

Suresh E, Abrahamsen B. Suresh E, et al. Cleve Clin J Med. 2015 Feb;82(2):105-14. doi: 10.3949/ccjm.82a.13173. Cleve Clin J Med. 2015. PMID: 25897599 Free article. Review.

9

Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment.

Anastasilakis AD, Yavropoulou MP, Makras P, Sakellariou GT, Papadopoulou F, Gerou S, Papapoulos SE. Anastasilakis AD, et al. Eur J Endocrinol. 2017 Jun;176(6):677-683. doi: 10.1530/EJE-16-1027. Epub 2017 Mar 10. Eur J Endocrinol. 2017. PMID: 28283537

10

Stopping Denosumab.

Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG. Lamy O, et al. Curr Osteoporos Rep. 2019 Feb;17(1):8-15. doi: 10.1007/s11914-019-00502-4. Curr Osteoporos Rep. 2019. PMID: 30659428 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year